{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:36:52Z","timestamp":1794278212628,"version":"4.9.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063744"],"award-info":[{"award-number":["U19AG063744"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG058942"],"award-info":[{"award-number":["RF1AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG059093"],"award-info":[{"award-number":["RF1AG059093"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG061359"],"award-info":[{"award-number":["U01AG061359"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG057452"],"award-info":[{"award-number":["RF1AG057452"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063744"],"award-info":[{"award-number":["U19AG063744"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG058942"],"award-info":[{"award-number":["RF1AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG063744"],"award-info":[{"award-number":["U19AG063744"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG058942"],"award-info":[{"award-number":["RF1AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG059093"],"award-info":[{"award-number":["R01AG059093"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG057452"],"award-info":[{"award-number":["RF1AG057452"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG046171"],"award-info":[{"award-number":["R01AG046171"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG051550"],"award-info":[{"award-number":["RF1AG051550"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG061359"],"award-info":[{"award-number":["U01AG061359"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["536691227"],"award-info":[{"award-number":["536691227"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["#733050814"],"award-info":[{"award-number":["#733050814"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford-GSK Institute of Molecular and Computational Medicine"},{"name":"FNIH #DAOU16AMPA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic alterations are increasingly implicated in neurological disorders, including Alzheimer\u2019s disease (AD), highlighting the relevance of the peripheral metabolome, shaped by genetic and environmental exposures, for brain health. We examined the relation of 991 blood metabolites with cognition and magnetic resonance imaging (MRI) measures cross-sectionally in 1,082 dementia-free middle-aged participants of the population-based Rotterdam Study and quantified contributions of genetic variation, lifestyle, comorbidities, medication and gut microbiota to metabolite variance. Cognition-associated metabolites were replicated in two independent cohorts of older adults and tested for associations with incident AD longitudinally in one cohort. Twenty-two metabolites were associated with MRI measures. Fourteen metabolites showed replicated associations with cognition, with ergothioneine exhibiting the largest effect. The metabolite signature of cognition mirrored that of incident AD. Lifestyle, clinical variables and medication were the strongest determinants of cognition-associated and MRI-associated metabolites, explaining up to 28.6% of their variance. Antacid use was associated with worse cognition and lower ergothioneine levels, which mediated 31.5% of the negative medication effect, suggesting implications for AD prevention.<\/jats:p>","DOI":"10.1038\/s43587-026-01149-4","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:02:40Z","timestamp":1782291760000},"page":"1452-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The blood metabolome of brain health in midlife and influences of genes, microbiome and exposome"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-3790","authenticated-orcid":false,"given":"Shahzad","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-3380","authenticated-orcid":false,"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0923","authenticated-orcid":false,"given":"Matthias","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-2073","authenticated-orcid":false,"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-7143","authenticated-orcid":false,"given":"Mohsen","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady","family":"Roshchupkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 G.","family":"Uitterlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Borkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5739-466X","authenticated-orcid":false,"given":"Julia","family":"Neitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kraaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Alzheimer\u2019s Disease Metabolomics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-9204","authenticated-orcid":false,"given":"Cornelia M.","family":"van Duijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-8585","authenticated-orcid":false,"given":"M. Arfan","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-5732","authenticated-orcid":false,"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-7322","authenticated-orcid":false,"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"1149_CR1","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma, V. R. et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 15, e1002482 (2018).","journal-title":"PLoS Med."},{"key":"1149_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","volume":"12","author":"R Casanova","year":"2016","unstructured":"Casanova, R. et al. Blood metabolite markers of preclinical Alzheimer\u2019s disease in two longitudinally followed cohorts of older individuals. Alzheimers Dement. 12, 815\u2013822 (2016).","journal-title":"Alzheimers Dement."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","volume":"86","author":"Z Huo","year":"2020","unstructured":"Huo, Z. et al. Brain and blood metabolome for Alzheimer\u2019s dementia: findings from a targeted metabolomics analysis. Neurobiol. Aging 86, 123\u2013133 (2020).","journal-title":"Neurobiol. Aging"},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.121.056892","volume":"145","author":"E Sliz","year":"2022","unstructured":"Sliz, E. et al. Circulating metabolome and white matter hyperintensities in women and men. Circulation 145, 1040\u20131052 (2022).","journal-title":"Circulation"},{"key":"1149_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-200176","volume":"79","author":"BF Darst","year":"2021","unstructured":"Darst, B. F. et al. Metabolites associated with early cognitive changes implicated in Alzheimer\u2019s disease. J. Alzheimers Dis. 79, 1041\u20131054 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"1149_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/alz.12180","volume":"17","author":"FA de Leeuw","year":"2021","unstructured":"de Leeuw, F. A. et al. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimers Dement. 17, 205\u2013214 (2021).","journal-title":"Alzheimers Dement."},{"key":"1149_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.118","volume":"7","author":"J Bressler","year":"2017","unstructured":"Bressler, J. et al. Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study. Transl. Psychiatry 7, e1173 (2017).","journal-title":"Transl. Psychiatry"},{"key":"1149_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","volume":"14","author":"J Tynkkynen","year":"2018","unstructured":"Tynkkynen, J. et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: a prospective study in eight cohorts. Alzheimers Dement. 14, 723\u2013733 (2018).","journal-title":"Alzheimers Dement."},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimers Dement. 13, 965\u2013984 (2017).","journal-title":"Alzheimers Dement."},{"key":"1149_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14959-w","volume":"11","author":"M Arnold","year":"2020","unstructured":"Arnold, M. et al. Sex and APOE \u03b54 genotype modify the Alzheimer\u2019s disease serum metabolome. Nat. Commun. 11, 1148 (2020).","journal-title":"Nat. Commun."},{"key":"1149_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19473-7","volume":"11","author":"K Huynh","year":"2020","unstructured":"Huynh, K. et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer\u2019s disease. Nat. Commun. 11, 5698 (2020).","journal-title":"Nat. Commun."},{"key":"1149_CR12","doi-asserted-by":"publisher","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han, X. et al. Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS ONE 6, e21643 (2011).","journal-title":"PLoS ONE"},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone, M. et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20, 415\u2013418 (2014).","journal-title":"Nat. Med."},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","volume":"15","author":"K Nho","year":"2019","unstructured":"Nho, K. et al. Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: relationship to neuroimaging and CSF biomarkers. Alzheimers Dement. 15, 232\u2013244 (2019).","journal-title":"Alzheimers Dement."},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jalz.2017.11.012","volume":"14","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee, S. J. et al. Circulating metabolites and general cognitive ability and dementia: evidence from 11 cohort studies. Alzheimers Dement. 14, 707\u2013722 (2018).","journal-title":"Alzheimers Dement."},{"key":"1149_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni, G. B., Fox, N. C., Jack, C. R. Jr., Scheltens, P. & Thompson, P. M. The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6, 67\u201377 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"1149_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.trci.2018.04.007","volume":"4","author":"E Bayram","year":"2018","unstructured":"Bayram, E., Caldwell, J. Z. K. & Banks, S. J. Current understanding of magnetic resonance imaging biomarkers and memory in Alzheimer\u2019s disease. Alzheimers Dement. (N Y) 4, 395\u2013413 (2018).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1532-5415.2012.03956.x","volume":"60","author":"LA Rabin","year":"2012","unstructured":"Rabin, L. A. et al. Predicting Alzheimer\u2019s disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties. J. Am. Geriatr. Soc. 60, 1128\u20131134 (2012).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1149_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13195-022-01082-9","volume":"14","author":"MA Parra","year":"2022","unstructured":"Parra, M. A., Calia, C., Pattan, V. & Della Sala, S. Memory markers in the continuum of the Alzheimer\u2019s clinical syndrome. Alzheimers Res. Ther. 14, 142 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1149_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neurobiolaging.2006.11.018","volume":"29","author":"NS Schoonenboom","year":"2008","unstructured":"Schoonenboom, N. S. et al. CSF and MRI markers independently contribute to the diagnosis of Alzheimer\u2019s disease. Neurobiol. Aging 29, 669\u2013675 (2008).","journal-title":"Neurobiol. Aging"},{"key":"1149_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13195-018-0428-1","volume":"10","author":"M Ten Kate","year":"2018","unstructured":"Ten Kate, M. et al. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimers Res. Ther. 10, 100 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann. Neurol. 79, 929\u2013939 (2016).","journal-title":"Ann. Neurol."},{"key":"1149_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34422-2","volume":"13","author":"L Maitre","year":"2022","unstructured":"Maitre, L. et al. Multi-omics signatures of the human early life exposome. Nat. Commun. 13, 7024 (2022).","journal-title":"Nat. Commun."},{"key":"1149_CR24","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4155\/bio.12.211","volume":"4","author":"TJ Athersuch","year":"2012","unstructured":"Athersuch, T. J. The role of metabolomics in characterizing the human exposome. Bioanalysis 4, 2207\u20132212 (2012).","journal-title":"Bioanalysis"},{"key":"1149_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-020-2896-2","volume":"588","author":"N Bar","year":"2020","unstructured":"Bar, N. et al. A reference map of potential determinants for the human serum metabolome. Nature 588, 135\u2013140 (2020).","journal-title":"Nature"},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41591-022-02014-8","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat. Med. 28, 2333\u20132343 (2022).","journal-title":"Nat. Med."},{"key":"1149_CR27","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1038\/s41591-022-02046-0","volume":"28","author":"P Surendran","year":"2022","unstructured":"Surendran, P. et al. Rare and common genetic determinants of metabolic individuality and their effects on human health. Nat. Med. 28, 2321\u20132332 (2022).","journal-title":"Nat. Med."},{"key":"1149_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321\u2013332 (2021).","journal-title":"Nat. Med."},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/cdd.2009.163","volume":"17","author":"BD Paul","year":"2010","unstructured":"Paul, B. D. & Snyder, S. H. The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. 17, 1134\u20131140 (2010).","journal-title":"Cell Death Differ."},{"key":"1149_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka, T. et al. Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s Disease Neuroimaging Initiative cohort. Sci. Rep. 14, 6797 (2024).","journal-title":"Sci. Rep."},{"key":"1149_CR31","doi-asserted-by":"publisher","unstructured":"Zhao, D. et al. Associations of plasma ergothioneine levels with cognitive function change in non-demented older Chinese adults: a community-based longitudinal study. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.07.16.25331363 (2025).","DOI":"10.1101\/2025.07.16.25331363"},{"key":"1149_CR32","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/alz.12714","volume":"19","author":"R Batra","year":"2023","unstructured":"Batra, R. et al. The landscape of metabolic brain alterations in Alzheimer\u2019s disease. Alzheimers Dement. 19, 980\u2013998 (2023).","journal-title":"Alzheimers Dement."},{"key":"1149_CR33","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/alz.12800","volume":"19","author":"BC Novotny","year":"2023","unstructured":"Novotny, B. C. et al. Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains. Alzheimer's Dement. 19, 1785\u20131799 (2023).","journal-title":"Alzheimer's Dement."},{"key":"1149_CR34","doi-asserted-by":"crossref","unstructured":"Beelman, R. B., Kalaras, M. D., Phillips, A. T. & Richie, J. P. Is ergothioneine a \u2018longevity vitamin\u2019 limited in the American diet? J. Nutr. Sci. 9, e52 (2020).","DOI":"10.1017\/jns.2020.44"},{"key":"1149_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2016.07.074","volume":"478","author":"IK Cheah","year":"2016","unstructured":"Cheah, I. K., Feng, L., Tang, R. M. Y., Lim, K. H. C. & Halliwell, B. Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochem. Biophys. Res. Commun. 478, 162\u2013167 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1149_CR36","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1073\/pnas.0408624102","volume":"102","author":"D Gr\u00fcndemann","year":"2005","unstructured":"Gr\u00fcndemann, D. et al. Discovery of the ergothioneine transporter. Proc. Natl Acad. Sci. USA 102, 5256\u20135261 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1149_CR37","doi-asserted-by":"crossref","unstructured":"Forgacs, I. & Loganayagam, A. Overprescribing proton pump inhibitors. BMJ 336, 2\u22123 (2008).","DOI":"10.1136\/bmj.39406.449456.BE"},{"key":"1149_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm, W. et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol. 73, 410\u2013416 (2016).","journal-title":"JAMA Neurol."},{"key":"1149_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/alz.13477","volume":"20","author":"N Pourhadi","year":"2024","unstructured":"Pourhadi, N. et al. Proton pump inhibitors and dementia: a nationwide population-based study. Alzheimers Dement. 20, 837\u2013845 (2024).","journal-title":"Alzheimers Dement."},{"key":"1149_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/0115672050289946240223050737","volume":"20","author":"Z Khan","year":"2024","unstructured":"Khan, Z. et al. Proton pump inhibitors and cognitive health: review on unraveling the dementia connection and co-morbid risks. Curr. Alzheimer Res. 20, 739\u2013757 (2024).","journal-title":"Curr. Alzheimer Res."},{"key":"1149_CR41","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1001\/jama.2013.280490","volume":"310","author":"JR Lam","year":"2013","unstructured":"Lam, J. R., Schneider, J. L., Zhao, W. & Corley, D. A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310, 2435\u20132442 (2013).","journal-title":"JAMA"},{"key":"1149_CR42","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ebiom.2019.08.032","volume":"47","author":"R Nagpal","year":"2019","unstructured":"Nagpal, R., Neth, B. J., Wang, S., Craft, S. & Yadav, H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer\u2019s disease markers in subjects with mild cognitive impairment. EBioMedicine 47, 529\u2013542 (2019).","journal-title":"EBioMedicine"},{"key":"1149_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1, 6ra14 (2009).","journal-title":"Sci. Transl. Med."},{"key":"1149_CR44","doi-asserted-by":"crossref","unstructured":"Radjabzadeh, D. et al. Gut microbiome-wide association study of depression. Nat. Commun. 13, 7128 (2022).","DOI":"10.1038\/s41467-022-34502-3"},{"key":"1149_CR45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1058-x","volume":"568","author":"S Nayfach","year":"2019","unstructured":"Nayfach, S., Shi, Z. J., Seshadri, R., Pollard, K. S. & Kyrpides, N. C. New insights from uncultivated genomes of the global human gut microbiome. Nature 568, 505\u2013510 (2019).","journal-title":"Nature"},{"key":"1149_CR46","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/jcm10091809","volume":"10","author":"O S\u00e1iz-V\u00e1zquez","year":"2021","unstructured":"S\u00e1iz-V\u00e1zquez, O. et al. Depression as a risk factor for Alzheimer\u2019s disease: a systematic review of longitudinal meta-analyses. J. Clin. Med. 10, 1809 (2021).","journal-title":"J. Clin. Med."},{"key":"1149_CR47","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.3949\/ccjm.78.s1.07","volume":"78","author":"D Wint","year":"2011","unstructured":"Wint, D. Depression: a shared risk factor for cardiovascular and Alzheimer disease. Cleve. Clin. J. Med. 78, S44\u2013S46 (2011).","journal-title":"Cleve. Clin. J. Med."},{"key":"1149_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00040-6","volume":"8","author":"SC Wu","year":"2017","unstructured":"Wu, S. C., Cao, Z. S., Chang, K. M. & Juang, J. L. Intestinal microbial dysbiosis aggravates the progression of Alzheimer\u2019s disease in Drosophila. Nat. Commun. 8, 24 (2017).","journal-title":"Nat. Commun."},{"key":"1149_CR49","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbi.2019.05.008","volume":"80","author":"P Liu","year":"2019","unstructured":"Liu, P. et al. Altered microbiomes distinguish Alzheimer\u2019s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav. Immun. 80, 633\u2013643 (2019).","journal-title":"Brain Behav. Immun."},{"key":"1149_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00769-006-0157-1","volume":"11","author":"I \u0160perlingov\u00e1","year":"2006","unstructured":"\u0160perlingov\u00e1, I., Dabrowsk\u00e1, L., Str\u00e1nsk\u00fd, V., Ku\u010dera, J. & Tich\u00fd, M. Preliminary study to prepare a reference material of toluene metabolite \u2013 o-cresol and benzene metabolite-phenol \u2013 in human urine. Accredit. Qual. Assur. 11, 231\u2013235 (2006).","journal-title":"Accredit. Qual. Assur."},{"key":"1149_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00386931","volume":"63","author":"G Nise","year":"1992","unstructured":"Nise, G. Urinary excretion of O-cresol and hippuric acid after toluene exposure in rotogravure printing. Int. Arch. Occup. Environ. Health 63, 377\u2013381 (1992).","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"1149_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 10, 819\u2013828 (2011).","journal-title":"Lancet Neurol."},{"key":"1149_CR53","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","volume":"10","author":"TC Durazzo","year":"2014","unstructured":"Durazzo, T. C., Mattsson, N. & Weiner, M. W. Alzheimer\u2019s Disease Neuroimaging Initiative. Smoking and increased Alzheimer\u2019s disease risk: a review of potential mechanisms. Alzheimers Dement. 10, S122\u2013S145 (2014).","journal-title":"Alzheimers Dement."},{"key":"1149_CR54","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.1424638112","volume":"112","author":"RS Jansen","year":"2015","unstructured":"Jansen, R. S. et al. N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc. Natl Acad. Sci. USA 112, 6601\u20136606 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1149_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-022-04828-5","volume":"606","author":"VL Li","year":"2022","unstructured":"Li, V. L. et al. An exercise-inducible metabolite that suppresses feeding and obesity. Nature 606, 785\u2013790 (2022).","journal-title":"Nature"},{"key":"1149_CR56","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1007\/s00125-024-06282-6","volume":"67","author":"S Sharma","year":"2024","unstructured":"Sharma, S. et al. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study. Diabetologia 67, 2804\u20132818 (2024).","journal-title":"Diabetologia"},{"key":"1149_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s42255-024-00999-9","volume":"6","author":"S Xiao","year":"2024","unstructured":"Xiao, S. et al. Lac-Phe mediates the effects of metformin on food intake and body weight. Nat. Metab. 6, 659\u2013669 (2024).","journal-title":"Nat. Metab."},{"key":"1149_CR58","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-024-01018-7","volume":"6","author":"B Scott","year":"2024","unstructured":"Scott, B. et al. Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans. Nat. Metab. 6, 651\u2013658 (2024).","journal-title":"Nat. Metab."},{"key":"1149_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00470","volume":"21","author":"JW Kang","year":"2024","unstructured":"Kang, J. W. et al. Gut microbial metabolism in Alzheimer\u2019s disease and related dementias. Neurotherapeutics 21, e00470 (2024).","journal-title":"Neurotherapeutics"},{"key":"1149_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab291","volume":"4","author":"R Green","year":"2022","unstructured":"Green, R. et al. Metabolic correlates of late midlife cognitive outcomes: findings from the 1946 British Birth Cohort. Brain Commun. 4, fcab291 (2022).","journal-title":"Brain Commun."},{"key":"1149_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi, S. et al. Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2014an emerging role for gut microbiome. Alzheimers Dement. 15, 76\u201392 (2019).","journal-title":"Alzheimers Dement."},{"key":"1149_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuroscience.2018.10.001","volume":"394","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Study on urine metabolic profile of A\u03b225\u201335-induced Alzheimer\u2019s disease using UHPLC-Q-TOF-MS. Neuroscience 394, 30\u201343 (2018).","journal-title":"Neuroscience"},{"key":"1149_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00694-5","volume":"18","author":"KC Paul","year":"2023","unstructured":"Paul, K. C. et al. Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson\u2019s disease. Mol. Neurodegener. 18, 100 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1149_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01296-6","volume":"16","author":"SC Raju","year":"2024","unstructured":"Raju, S. C. et al. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. Genome Med. 16, 27 (2024).","journal-title":"Genome Med."},{"key":"1149_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2022.2073175","volume":"11","author":"AV Stachulski","year":"2023","unstructured":"Stachulski, A. V., Knausenberger, T. B., Shah, S. N., Hoyles, L. & McArthur, S. A host\u2013gut microbial amino acid co-metabolite, p-cresol glucuronide, promotes blood\u2013brain barrier integrity in vivo. Tissue Barriers 11, 2073175 (2023).","journal-title":"Tissue Barriers"},{"key":"1149_CR66","volume":"12","author":"FA de Leeuw","year":"2020","unstructured":"de Leeuw, F. A. et al. LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer\u2019s disease: the NUDAD project. Alzheimers Dement. (Amst.) 12, e12120 (2020).","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"1149_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","volume":"35","author":"MA Ikram","year":"2020","unstructured":"Ikram, M. A. et al. Objectives, design and main findings until 2020 from the Rotterdam Study. Eur. J. Epidemiol. 35, 483\u2013517 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"1149_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jad.2022.09.145","volume":"320","author":"JL Zijlmans","year":"2023","unstructured":"Zijlmans, J. L., Vernooij, M. W., Ikram, M. A. & Luik, A. I. The role of cognitive and brain reserve in late-life depressive events: the Rotterdam Study. J. Affect. Disord. 320, 211\u2013217 (2023).","journal-title":"J. Affect. Disord."},{"key":"1149_CR69","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/aje\/155.4.332","volume":"155","author":"R Vliegenthart","year":"2002","unstructured":"Vliegenthart, R. et al. Alcohol consumption and risk of peripheral arterial disease: the Rotterdam Study. Am. J. Epidemiol. 155, 332\u2013338 (2002).","journal-title":"Am. J. Epidemiol."},{"key":"1149_CR70","doi-asserted-by":"crossref","unstructured":"Lu, Z. et al. Burden of cardiometabolic disorders and lifetime risk of new-onset atrial fibrillation among men and women: the Rotterdam Study. Eur. J. Prev. Cardiol. 31, 1141\u22121149 (2024).","DOI":"10.1093\/eurjpc\/zwae045"},{"key":"1149_CR71","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955\u2013959 (2012).","journal-title":"Nat. Genet."},{"key":"1149_CR72","doi-asserted-by":"publisher","first-page":"1061\u22121073","DOI":"10.1038\/nature09534","volume":"467","author":"The 1000 Genomes Project Consortium et al.","year":"2010","unstructured":"The 1000 Genomes Project Consortium et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061\u22121073 (2010).","journal-title":"Nature"},{"key":"1149_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-018-1420-2","volume":"14","author":"KT Do","year":"2018","unstructured":"Do, K. T. et al. Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies. Metabolomics 14, 128 (2018).","journal-title":"Metabolomics"},{"key":"1149_CR74","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41598-020-57734-z","volume":"10","author":"D Radjabzadeh","year":"2020","unstructured":"Radjabzadeh, D. et al. Diversity, compositional and functional differences between gut microbiota of children and adults. Sci. Rep. 10, 1040 (2020).","journal-title":"Sci. Rep."},{"key":"1149_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2105-11-341","volume":"11","author":"R Schmieder","year":"2010","unstructured":"Schmieder, R., Lim, Y. W., Rohwer, F. & Edwards, R. TagCleaner: identification and removal of tag sequences from genomic and metagenomic datasets. BMC Bioinformatics 11, 341 (2010).","journal-title":"BMC Bioinformatics"},{"key":"1149_CR76","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"1149_CR77","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1149_CR78","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261\u20135267 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"1149_CR79","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"1149_CR80","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/bioinformatics\/btq706","volume":"27","author":"KP Schliep","year":"2011","unstructured":"Schliep, K. P. phangorn: phylogenetic analysis in R. Bioinformatics. 27, 592\u2013593 (2011).","journal-title":"Bioinformatics."},{"key":"1149_CR81","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10654-014-9885-4","volume":"29","author":"YY Hoogendam","year":"2014","unstructured":"Hoogendam, Y. Y., Hofman, A., van der Geest, J. N., van der Lugt, A. & Ikram, M. A. Patterns of cognitive function in aging: the Rotterdam Study. Eur. J. Epidemiol. 29, 133\u2013140 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"1149_CR82","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.neuroimage.2009.01.011","volume":"45","author":"R de Boer","year":"2009","unstructured":"de Boer, R. et al. White matter lesion extension to automatic brain tissue segmentation on MRI. Neuroimage 45, 1151\u20131161 (2009).","journal-title":"Neuroimage"},{"key":"1149_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuroimage.2007.05.018","volume":"37","author":"HA Vrooman","year":"2007","unstructured":"Vrooman, H. A. et al. Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification. Neuroimage 37, 71\u201381 (2007).","journal-title":"Neuroimage"},{"key":"1149_CR84","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10654-015-0105-7","volume":"30","author":"MA Ikram","year":"2015","unstructured":"Ikram, M. A. et al. The Rotterdam Scan Study: design update 2016 and main findings. Eur. J. Epidemiol. 30, 1299\u20131315 (2015).","journal-title":"Eur. J. Epidemiol."},{"key":"1149_CR85","doi-asserted-by":"crossref","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2212300 (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"1149_CR86","unstructured":"Pinheiro, J. et al. Package \u2018nlme\u2019: linear and nonlinear mixed effects models. R package version 3.1-137. http:\/\/CRAN.R-project.org\/package=nlme (2018)."},{"key":"1149_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"1149_CR88","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12038-019-9930-2","volume":"44","author":"SA Shetty","year":"2019","unstructured":"Shetty, S. A. & Lahti, L. Microbiome data science. J. Biosci. 44, 115 (2019).","journal-title":"J. Biosci."},{"key":"1149_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/srep36076","volume":"6","author":"GV Roshchupkin","year":"2016","unstructured":"Roshchupkin, G. V. et al. HASE: framework for efficient high-dimensional association analyses. Sci. Rep. 6, 36076 (2016).","journal-title":"Sci. Rep."},{"key":"1149_CR90","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"1149_CR91","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1073\/pnas.1415603112","volume":"112","author":"T Ge","year":"2015","unstructured":"Ge, T. et al. Massively expedited genome-wide heritability analysis (MEGHA). Proc. Natl Acad. Sci. USA 112, 2479\u20132484 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01149-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01149-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:02:01Z","timestamp":1784206921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01149-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":91,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1038\/s43587-026-01149-4","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.K.-D., G.K. and M.A. are inventors on a series of patents on the use of metabolomics for the diagnosis and treatment of central nervous system diseases and hold equity in Chymia LLC. R.K.-D. also holds equity in Metabolon Inc. and Metabosensor. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}